Woolson Daniel 4
Research Summary
AI-generated summary
ICU Medical (ICUI) VP Daniel Woolson Receives 19,885 Shares via PRSUs
What Happened
- Daniel Woolson, VP and GM—Infusion Capital at ICU Medical (ICUI), had performance-based restricted stock units (PRSU/RSU) convert to 19,885 shares on March 7–8, 2026 after performance results were certified. There was no exercise price for these awards (exercise price $0).
- To satisfy tax-withholding obligations, 8,209 of those shares were surrendered at $132.00 per share, generating withholding value of $1,083,588. Net new shares added to his account = 11,676 (19,885 acquired − 8,209 withheld).
- The filing reports conversion/exercise (code M) of the PRSUs/RSUs and share-withholding for taxes (code F); some derivative entries are reported as disposals with $0 proceeds reflecting conversion/settlement mechanics rather than open-market sales.
Key Details
- Transaction dates: March 7–8, 2026. Withholding price used: $132.00 per share.
- Shares acquired via conversion/settlement (M): 19,885 total (1,585 on 3/7; 16,147 and 2,153 on 3/8).
- Shares withheld for taxes (F): 702, 6,877, and 630 on the respective settlement dates (total 8,209); withholding value ≈ $1,083,588.
- Exercise/purchase price: $0 (these are RSUs/PRSUs — no purchase price).
- Shares owned after the transaction: not specified in the filing.
- Notable footnotes: PRSUs were granted 3/8/2024 and certified at 250% of target (footnote F1). Footnotes also confirm these are RSUs/PRSUs with time- and performance-based vesting and no exercise price (F2–F9).
- Filing timeliness: Report filed 2026-03-09 for transactions on 3/7–3/8 — filed within the usual two-business-day Form 4 window (timely).
Context
- These transactions are the settlement of performance and restricted stock unit awards, not open-market purchases or discretionary sales. The tax-related share "disposals" are routine withholding to cover tax liability, not indicative of an investment decision to sell shares on the market.
- Transaction codes: M = exercise/conversion of derivative (here, conversion of PRSUs/RSUs into shares); F = payment of exercise price or tax liability (share withholding).